Item Details
Norwegian Biotech Startup Vitroscope Raises USD 7 Million
On 3 November, Trondheim-based Vitroscope announced USD 7 million in funding, including a USD 5 million seed round co-led by Cerberus Ventures and YZR Capital and USD 2 million in non-dilutive funding from the Research Council of Norway. The investment will support the commercial rollout of its live-tissue research platform and development of a higher-throughput system. The deal creates opportunities for life-science investors, laboratory suppliers and research partners. HPC can support startup market research, investor presentations and funding strategy.
Get in Touch
We’ll get back to you shortly.